Is Nath Bio-Genes (India) stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Nath Bio-Genes (India) pays dividends. Last time was Monday 16th of September 2024 where the investors holding the stock on Friday 9th of August 2024 were paid INR2 per share. Over the last 5 times between 2021 and 2024, Nath Bio-Genes (India) has paid INR10 with an average of INR2 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Nath Bio-Genes (India) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR350.95, you would have made a loss of INR-133.11 per share or -37.93%
Yes, the average daily trading liquidity for Nath Bio-Genes (India) is INR124 241 thousand. You should therefore be able to get in and out of your positions relatively fast.
Nath Bio-Genes (India) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.04, the company's ability to pay off the debt is limited. Nath Bio-Genes (India) has a good net profit margin of 12.24% and should have high tolerances against inflation.
We have calculated the inflation risk for Nath Bio-Genes (India) to be medium [0.55 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.